Search - tctmd.com

Displaying 1 - 20 of 50

Sort: Relevancy | Date

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Daily News

Most PCIs in US Now Done With Radial Access

Michael O'Riordan

July 10, 2025

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News EACTS 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Michael O'Riordan

October 11, 2023

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access

Michael O'Riordan

February 05, 2021

News Daily News

CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR

Todd Neale

December 30, 2020

News Daily News

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

Todd Neale

November 25, 2020

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Daily News

Transradial Route Gains Support as Default for Secondary TAVR Access

Yael L. Maxwell

March 02, 2020

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

Advertisement

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Most PCIs in US Now Done With Radial Access

June 2024 Dispatch for the CV Team

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Top Coronary Artery Disease News of 2022

Worse Complications After PVI in Women Highlight Research Gaps

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

July/August 2021 News Roundup

Observational Study Supports Continuing Oral Anticoagulation During PCI

Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access

CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

March 2020 News Roundup

Transradial Route Gains Support as Default for Secondary TAVR Access

TCTMD’s Top 10 Most Popular Stories for June 2019

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content